1997
DOI: 10.1006/jmbi.1997.0915
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of NADP+ binding to perdeuterated MurB: backbone atom NMR assignments and chemical-shift changes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
41
0

Year Published

1998
1998
2020
2020

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 50 publications
(43 citation statements)
references
References 54 publications
2
41
0
Order By: Relevance
“…MurB confirmed that both substrates use the same binding pocket of the enzyme; this result is consistent with the role of the bound FAD cofactor in mediating hydride transfer from the NADPH to the UDP-sugar substrate [23]. The maximum number of poses per ligand was set to 30, and no constraints were used to perform molecular docking.…”
Section: Molecular Modeling Studysupporting
confidence: 67%
“…MurB confirmed that both substrates use the same binding pocket of the enzyme; this result is consistent with the role of the bound FAD cofactor in mediating hydride transfer from the NADPH to the UDP-sugar substrate [23]. The maximum number of poses per ligand was set to 30, and no constraints were used to perform molecular docking.…”
Section: Molecular Modeling Studysupporting
confidence: 67%
“…The likely docking site of NAD ϩ suggests hydride transfer from the isoalloxazine ring to a pyridine ring positioned at the si face. This unusual stereochemistry was also suggested for the interaction of MurB with NADP ϩ (29).…”
Section: Mmentioning
confidence: 56%
“…5a) Fig. 5b shows the difference between the conformational shifts of the C␣ and C␤ carbons over the entire C-terminal domain, which have been shown to be a convenient method for secondary structure identification in peptides and proteins (35)(36)(37). Overall, the C-terminal domain of Ste20p has helical preferences over most residues (Fig.…”
Section: Conformational Properties Of a 14-residue Gbb Peptide-mentioning
confidence: 98%